{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:30:12Z","timestamp":1778509812618,"version":"3.51.4"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Walgreens Co"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,13]]},"DOI":"10.1093\/infdis\/jiaa544","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T05:31:14Z","timestamp":1598074274000},"page":"355-358","source":"Crossref","is-referenced-by-count":10,"title":["Guillain-Barr\u00e9 Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence"],"prefix":"10.1093","volume":"223","author":[{"given":"Daniel A","family":"Salmon","sequence":"first","affiliation":[{"name":"Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew Z","family":"Dudley","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce C","family":"Carleton","sequence":"additional","affiliation":[{"name":"Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, Canada"},{"name":"British Columbia Children\u2019s Hospital Research Institute, University of British Columbia, Vancouver, Canada"},{"name":"Pharmaceutical Outcomes Program, British Columbia Children\u2019s Hospital, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"2021101012032533600_CIT0001","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2019\u201320 influenza season","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021101012032533600_CIT0002","first-page":"1057","article-title":"Estimates of deaths associated with seasonal influenza\u2014United States, 1976\u20132007","volume":"59","author":"Centers for Disease Control and Prevention.","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021101012032533600_CIT0003","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"2021101012032533600_CIT0004","doi-asserted-by":"crossref","first-page":"e66312","DOI":"10.1371\/journal.pone.0066312","article-title":"Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005\u20132011","volume":"8","author":"Kostova","year":"2013","journal-title":"PLoS One"},{"key":"2021101012032533600_CIT0005","author":"Centers for Disease Control and Prevention."},{"key":"2021101012032533600_CIT0006","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention;","year":"2015","edition":"13th ed"},{"key":"2021101012032533600_CIT0007","author":"Centers for Disease Control and Prevention."},{"key":"2021101012032533600_CIT0008","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"2021101012032533600_CIT0009","doi-asserted-by":"crossref","first-page":"D66","DOI":"10.1016\/j.vaccine.2015.09.035","article-title":"Vaccine hesitancy: causes, consequences, and a call to action","volume":"33","author":"Salmon","year":"2015","journal-title":"Vaccine"},{"key":"2021101012032533600_CIT0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/1090198112463022","article-title":"The role of attitudes about vaccine safety, efficacy, and value in explaining parents\u2019 reported vaccination behavior","volume":"40","author":"Lavail","year":"2013","journal-title":"Health Educ Behav"},{"key":"2021101012032533600_CIT0011","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1542\/peds.2010-1722L","article-title":"Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program","volume":"127","author":"Salmon","year":"2011","journal-title":"Pediatrics"},{"key":"2021101012032533600_CIT0012","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1016\/j.vaccine.2015.10.080","article-title":"The safety of influenza vaccines in children: an Institute for Vaccine Safety white paper","volume":"33","author":"Halsey","year":"2015","journal-title":"Vaccine"},{"key":"2021101012032533600_CIT0013","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S1473-3099(20)30130-4","article-title":"The state of vaccine safety science: systematic reviews of the evidence","volume":"20","author":"Dudley","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2021101012032533600_CIT0014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"2021101012032533600_CIT0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain-Barr\u00e9 syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"key":"2021101012032533600_CIT0016","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/oxfordjournals.aje.a113810","article-title":"Guillain-Barr\u00e9 syndrome and its relationship to swine influenza vaccination in Michigan, 1976\u20131977","volume":"119","author":"Breman","year":"1984","journal-title":"Am J Epidemiol"},{"key":"2021101012032533600_CIT0017","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a115973","article-title":"Reassessment of the association between Guillain-Barr\u00e9 syndrome and receipt of swine influenza vaccine in 1976\u20131977: results of a two-state study. Expert Neurology Group","volume":"133","author":"Safranek","year":"1991","journal-title":"Am J Epidemiol"},{"key":"2021101012032533600_CIT0018","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amepre.2010.05.022","article-title":"Evaluation of Guillain-Barre syndrome among recipients of influenza vaccine in 2000 and 2001","volume":"39","author":"Burwen","year":"2010","journal-title":"Am J Prev Med"},{"key":"2021101012032533600_CIT0019","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.166.12.1301","article-title":"No association between immunization and Guillain-Barre syndrome in the United Kingdom, 1992 to 2000","volume":"166","author":"Hughes","year":"2006","journal-title":"Arch Intern Med"},{"key":"2021101012032533600_CIT0020","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198106253042601","article-title":"Guillain-Barre syndrome and the 1978\u20131979 influenza vaccine","volume":"304","author":"Hurwitz","year":"1981","journal-title":"New Eng J Med"},{"key":"2021101012032533600_CIT0021","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain-Barr\u00e9 syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch Intern Med"},{"key":"2021101012032533600_CIT0022","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1982.03330060038030","article-title":"Guillain-Barre syndrome in the United States, 1979\u20131980 and 1980\u20131981","volume":"248","author":"Kaplan","year":"1982","journal-title":"J Am Med Assoc"},{"key":"2021101012032533600_CIT0023","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/oxfordjournals.aje.a115974","article-title":"Guillain-Barre syndrome and influenza vaccination in the US Army, 1980\u20131988","volume":"133","author":"Roscelli","year":"1991","journal-title":"Am J Epidemiol"},{"key":"2021101012032533600_CIT0024","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2021101012032533600_CIT0025","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pone.0000344","article-title":"Guillain-Barr\u00e9 syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the general practice research database","volume":"2","author":"Tam","year":"2007","journal-title":"PLoS One"},{"key":"2021101012032533600_CIT0026","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/aje\/kwp345","article-title":"Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project","volume":"171","author":"Greene","year":"2010","journal-title":"Am J Epidemiol"},{"key":"2021101012032533600_CIT0027","volume-title":"Adverse effects of vaccines: evidence and causality","author":"Stratton","year":"2011"},{"key":"2021101012032533600_CIT0028","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"key":"2021101012032533600_CIT0029","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.vaccine.2013.06.032","article-title":"International collaboration to assess the risk of Guillain Barre syndrome following influenza A (H1N1) 2009 monovalent vaccines","volume":"31","author":"Dodd","year":"2013","journal-title":"Vaccine"},{"key":"2021101012032533600_CIT0030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/pds.3575","article-title":"Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barr\u00e9 syndrome, encephalitis, or anaphylaxis in the 2012\u20132013 season","volume":"23","author":"Kawai","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021101012032533600_CIT0031","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis","volume":"33","author":"Mart\u00edn Arias","year":"2015","journal-title":"Vaccine"},{"key":"2021101012032533600_CIT0032","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.vaccine.2017.03.087","article-title":"Near real-time surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among the Medicare population, 2010\/11 to 2013\/14","volume":"35","author":"Sandhu","year":"2017","journal-title":"Vaccine"},{"key":"2021101012032533600_CIT0033","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1016\/j.vaccine.2019.05.041","article-title":"Surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017\u20132018 season","volume":"37","author":"Perez-Vilar","year":"2019","journal-title":"Vaccine"},{"key":"2021101012032533600_CIT0034","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021101012032533600_CIT0035","volume-title":"Risk communication and vaccination: summary of a workshop","author":"US Institute of Medicine Vaccine Safety Forum.","year":"1997"},{"key":"2021101012032533600_CIT0036","volume-title":"Thinking, fast and slow","author":"Kahneman","year":"2011"},{"key":"2021101012032533600_CIT0037","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.2020.10802","article-title":"The dual epidemics of COVID-19 and influenza: vaccine acceptance, coverage, and mandates","volume":"324","author":"Gostin","year":"2020","journal-title":"JAMA"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa544\/34102755\/jiaa544.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/3\/355\/40544061\/jiaa544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/3\/355\/40544061\/jiaa544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T02:23:24Z","timestamp":1633919004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/3\/355\/5952166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,11,2]]},"published-print":{"date-parts":[[2021,2,13]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa544","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,11,2]]}}}